Sandoz Group

Perfil de la empresa

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company has a strategic collaboration with Shanghai Henlius Biotech, Inc. to broaden patient access to biosimilar medicines. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.

Descripción disponible en inglés.

Datos societarios

Sector

Salud

Industria

Drug Manufacturers - Specialty & Generic

País

Suiza

Sede

Centralbahnstrasse 4, 4051, Basel

Empleados

20.000

Cotización

SDZ · SIX

Índices

SMI

Divisa

CHF

ISIN

CH1243598427

Sitio web

sandoz.com